Clinical Roundup Genentech’s Itovebi demonstrated OS benefit in advanced breast cancer, phase III trial finds January 31, 2025Vol.51 No.04
Drugs & Targets FDA approves Enhertu as first HER2-directed therapy for breast cancer January 31, 2025Vol.51 No.04
Conversation with The Cancer LetterReal-world Evidence RWD company documents baseline trends in women’s cancers before Trump’s policy changes January 24, 2025Vol.51 No.03By Claire Marie Porter
Clinical Roundup SWOG study: Statistical tool provides more accurate estimates of recurrence risk and chemotherapy benefit in breast cancer January 24, 2025Vol.51 No.03
Clinical Roundup Trastuzumab emtansine improves OS in HER2+ breast cancer, phase III study shows January 17, 2025Vol.51 No.02
Clinical Roundup Drug in clinical trials for breast cancer could also treat some blood cancers, studies show January 17, 2025Vol.51 No.02
Clinical Roundup Breast cancer-causing gene predisposes Black women to TNBC January 17, 2025Vol.51 No.02
White House Fran Visco awarded the Presidential Citizens Medal: “We are not going to change what we do or how we do it.” January 10, 2025Vol.51 No.01By Claire Marie Porter
